Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 240
Filter
1.
Clin Microbiol Infect ; 25(12): 1539-1545, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31004768

ABSTRACT

OBJECTIVES: To determine the viral epidemiology and clinical characteristics of patients with and without clinically apparent respiratory tract infection. METHODS: This prospective cohort study was conducted during the 2018 winter influenza season. Adult patients with fever/respiratory symptoms (fever/RS group) were age- and sex-matched with patients without fever/RS (non-fever/RS group) in a 1:1 ratio. Respiratory viruses were tested using NxTAG™ Respiratory Pathogen Panel IVD, a commercially-available multiplex PCR panel. RESULTS: A total of 214 acutely hospitalized patients were included in the final analysis, consisting of 107 with fever/RS (fever/RS group), and 107 age- and sex-matched patients without fever/RS (non-fever/RS group). Respiratory viruses were detected in 34.1% (73/214) of patients, and co-infection occurred in 7.9% (17/214) of patients. The incidence of respiratory virus was higher in the fever/RS group than in the non-fever/RS group (44.9% (48/107) versus 23.4% (25/107), p 0.001). Influenza B virus, enterovirus/rhinovirus and coronaviruses were detected more frequently in the fever/RS group, whereas parainfluenza virus 4B and adenovirus were detected more frequently in the non-fever/RS group. Among the non-fever/RS group, chest discomfort was more common among patients tested positive for respiratory viruses than those without respiratory virus detected (44% (11/25) versus 22% (18/82), p 0.04). CONCLUSIONS: Respiratory viruses can be frequently detected among hospitalized patients without typical features of respiratory tract infection. These patients may be a source of nosocomial outbreaks.


Subject(s)
Asymptomatic Infections/epidemiology , Respiratory Tract Infections/epidemiology , Virus Diseases/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Coinfection/epidemiology , Coinfection/virology , Female , Hospitalization , Humans , Male , Middle Aged , Multiplex Polymerase Chain Reaction , Prospective Studies , Respiratory Tract Infections/pathology , Respiratory Tract Infections/virology , Saliva/virology , Virus Diseases/pathology , Virus Diseases/virology , Viruses/genetics , Viruses/isolation & purification , Young Adult
2.
Clin Microbiol Infect ; 25(3): 372-378, 2019 Mar.
Article in English | MEDLINE | ID: mdl-29906597

ABSTRACT

OBJECTIVES: Automated point-of-care molecular assays have greatly shortened the turnaround time of respiratory virus testing. One of the major bottlenecks now lies at the specimen collection step, especially in a busy clinical setting. Saliva is a convenient specimen type that can be provided easily by adult patients. This study assessed the diagnostic validity, specimen collection time and cost associated with the use of saliva. METHODS: This was a prospective diagnostic validity study comparing the detection rate of respiratory viruses between saliva and nasopharyngeal aspirate (NPA) among adult hospitalized patients using Xpert® Xpress Flu/RSV. The cost and time associated with the collection of saliva and nasopharyngeal specimens were also estimated. RESULTS: Between July and October 2017, 214 patients were recruited. The overall agreement between saliva and NPA was 93.3% (196/210, κ 0.851, 95% CI 0.776-0.926). There was no significant difference in the detection rate of respiratory viruses between saliva and NPA (32.9% (69/210) versus 35.7% (75/210); p 0.146). The overall sensitivity and specificity were 90.8% (81.9%-96.2%) and 100% (97.3%-100%), respectively, for saliva, and were 96.1% (88.9%-99.2%) and 98.5% (94.7%-99.8%), respectively, for NPA. The time and cost associated with the collection of saliva were 2.26-fold and 2.59-fold lower, respectively, than those of NPA. CONCLUSIONS: Saliva specimens have high sensitivity and specificity in the detection of respiratory viruses by an automated multiplex Clinical Laboratory Improvement Amendments-waived point-of-care molecular assay when compared with those of NPA. The use of saliva also reduces the time and cost associated with specimen collection.


Subject(s)
Molecular Diagnostic Techniques/methods , Point-of-Care Testing , Respiratory Tract Infections/diagnosis , Specimen Handling/methods , Aged , Aged, 80 and over , Costs and Cost Analysis , Female , Humans , Influenza A virus/isolation & purification , Influenza B virus/isolation & purification , Male , Middle Aged , Molecular Diagnostic Techniques/standards , Nasopharynx/virology , Prospective Studies , Reproducibility of Results , Respiratory Syncytial Viruses/isolation & purification , Respiratory Tract Infections/virology , Saliva/virology , Sensitivity and Specificity , Specimen Handling/economics , Time Factors
3.
Article in English | MEDLINE | ID: mdl-21097247

ABSTRACT

A novel design of a hand functions task training robotic system was developed for the stroke rehabilitation. It detects the intention of hand opening or hand closing from the stroke person using the electromyography (EMG) signals measured from the hemiplegic side. This training system consists of an embedded controller and a robotic hand module. Each hand robot has 5 individual finger assemblies capable to drive 2 degrees of freedom (DOFs) of each finger at the same time. Powered by the linear actuator, the finger assembly achieves 55 degree range of motion (ROM) at the metacarpophalangeal (MCP) joint and 65 degree range of motion (ROM) at the proximal interphalangeal (PIP) joint. Each finger assembly can also be adjusted to fit for different finger length. With this task training system, stroke subject can open and close their impaired hand using their own intention to carry out some of the daily living tasks.


Subject(s)
Hand/physiopathology , Orthotic Devices , Physical Therapy Modalities/instrumentation , Robotics/instrumentation , Stroke Rehabilitation , Stroke/physiopathology , Therapy, Computer-Assisted/instrumentation , Equipment Design , Equipment Failure Analysis , Humans , Transducers
4.
Bioorg Med Chem Lett ; 11(20): 2715-7, 2001 Oct 22.
Article in English | MEDLINE | ID: mdl-11591508

ABSTRACT

A series of N(1)- and N(2)-propargylphenelzine derivatives and analogues (1-7) was synthesized. In addition to their activity as monoamine oxidase inhibitors, two of the compounds, N(1)- and N(2)-propargylphenelzines (3 and 6), were found to be potent at preventing DSP-4-induced noradrenaline (NA) depletion in mouse hippocampus, suggesting that they have neuroprotective properties.


Subject(s)
Neuroprotective Agents/chemical synthesis , Phenelzine/chemical synthesis , Animals , Hippocampus/drug effects , Hippocampus/metabolism , Mice , Monoamine Oxidase Inhibitors/chemical synthesis , Monoamine Oxidase Inhibitors/chemistry , Neuroprotective Agents/chemistry , Norepinephrine/metabolism , Phenelzine/analogs & derivatives , Phenelzine/chemistry , Phenelzine/pharmacology
5.
J Pharm Pharmacol ; 53(6): 849-57, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11428661

ABSTRACT

Alcoholic extracts of the roots and leaves of three Echinacea species (E. purpurea, E. angustifolia and E. pallida) were analysed for the presence of characteristic chemicals by HPLC directly coupled to ultraviolet absorbance and electrospray mass spectrometric detectors. The method permitted rapid characterization and tentative identification of a large number of caffeoyl conjugates and alkamides in all the samples investigated. The roots of the three species differed markedly in their contents of characteristic compounds. Cichoric acid and verbascoside predominated in extracts of E. purpurea root whereas cynarine and dodeca-2E,4E,8Z,10Z/E-tetraenoic acid isobutylamide were the major chemicals characteristic of E. angustifolia root extracts. Echinacoside and 6-O-caffeoylechinacoside predominated in extracts of E. pallida roots. Characteristic alkamides were also examined by electrospray tandem mass spectrometry (MS/MS) and these compounds provided characteristic fragmentation patterns. Extracts of the roots and leaves of all three species were found to have antioxidant properties in a free radical scavenging assay and in a lipid peroxidation assay.


Subject(s)
Antioxidants/pharmacology , Echinacea/chemistry , Plant Extracts/pharmacology , Plants, Medicinal , Chromatography, High Pressure Liquid , Free Radical Scavengers , Humans , Lipid Peroxidation , Mass Spectrometry , Neuroblastoma/pathology , Plant Extracts/chemistry , Plant Leaves/chemistry , Plant Roots/chemistry , Spectrophotometry, Ultraviolet , Tumor Cells, Cultured
7.
Am J Hypertens ; 13(11): 1173-9, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11078177

ABSTRACT

A new competitive enzyme immunoassay for the detection parathyroid hypertensive factor (PHF) in human plasma using a PHF-horseradish peroxidase conjugate and IgM antibody adsorbed on the microtiter plate was established. The antibodies raised against rat PHF could recognize human PHF. Cross-reactivity of anti-PHF antibodies with other serum haptens and proteins was negligible. Conjugation of PHF with horseradish peroxidase did not neutralize the antigen activity. The limit of detection of PHF was 0.02 U/mL in reference units and PHF levels between 0.02 and 1 U/mL could be detected. Within-run coefficient of variation (CV) was less than 10%, and between-run CV was less than 15% for over the dynamic range of the assay. Preliminary clinical studies were performed with plasma samples from hypertensive patients with confirmed diagnosis. Parathyroid hypertensive factor levels, as detected with this immunoassay, were positively correlated with PHF levels detected with the semiquantitative blood pressure (BP) bioassay previously used. Parathyroid hypertensive factor levels detected with the enzyme-linked immunosorbent assay (ELISA) were also correlated with BP in patients. The PHF ELISA provides a selective, simple, and rapid method that can be used for routine determination of PHF in human plasma, and provides useful clinical information.


Subject(s)
Biological Factors/blood , Enzyme-Linked Immunosorbent Assay/methods , Adult , Aged , Animals , Antibody Specificity , Biological Factors/immunology , Calcium Metabolism Disorders/etiology , Female , Humans , Male , Mice , Middle Aged , Rats , Rats, Sprague-Dawley
8.
Regul Pept ; 91(1-3): 83-8, 2000 Jul 28.
Article in English | MEDLINE | ID: mdl-10967204

ABSTRACT

Parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP) have been shown to relax various types of smooth muscle, e.g. vascular, uterine and gastric. This study demonstrates that PTH and PTHrP both relaxed cholecystokinin octapeptide (CCK)-induced tension in guinea pig gallbladder strips. This relaxation was concentration-dependent. The use of PTHrP (7-34) blocked the relaxant effect of both agents. This suggested PTH and PTHrP were acting through the same receptor. The use of Rp-cAMPs, an inhibitor of cAMP activation of protein kinase A, and H-89, a selective inhibitor of protein kinase A, suggested that cAMP mediated the relaxant action of PTH and PTHrP. The use of iberiotoxin indicated that the high conductance Ca(2+)-activated potassium channels also mediated the actions of PTH/PTHrP. The use of KT5823, a selective blocker of protein kinase G, also decreased the amount of relaxation induced by PTH/PTHrP. This suggested that crosstalk between the two second messenger (cAMP and cGMP) systems occurred.


Subject(s)
Carbazoles , Cholecystokinin/metabolism , Gallbladder/drug effects , Indoles , Parathyroid Hormone/pharmacology , Proteins/pharmacology , Alkaloids/pharmacology , Animals , Calcium Channels/drug effects , Cyclic AMP/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism , Cyclic GMP/metabolism , Cyclic GMP-Dependent Protein Kinases/antagonists & inhibitors , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Guinea Pigs , In Vitro Techniques , Male , Nitric Oxide/metabolism , Parathyroid Hormone/metabolism , Parathyroid Hormone-Related Protein , Peptides/pharmacology , Proteins/metabolism , Signal Transduction
9.
J Pharm Pharmacol ; 52(4): 451-9, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10813558

ABSTRACT

The effects of Ginkgo biloba leaf extract on rat brain or livermonoamine oxidase (MAO)-A and -B activity, biogenic amine concentration in nervous tissue, N-methyl-D-aspartate (NMDA)- and N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4)-induced neurotoxicity and antioxidant activity was investigated to determine the effects of the extract on monoamine catabolism and neuroprotection. Ginkgo biloba leaf extract was shown to produce in-vitro inhibition of rat brain MAO-A and -B. The Ginkgo biloba extract was chromatographed on a reverse-phase HPLC system and two of the components isolated were shown to be MAO inhibitors (MAOIs). These MAOIs were identified by high-resolution mass spectrometry as kaempferol and isorhamnetin. Pure kaempferol and a number of related flavonoids were examined as MAOIs in-vitro. Kaempferol, apigenin and chrysin proved to be potent MAOIs, but produced more pronounced inhibition of MAO-A than MAO-B. IC50 (50% inhibition concentration) values for the ability of these three flavones to inhibit MAO-A were 7 x 10(-7), 1 x 10(-6) and 2 x 10(-6) M, respectively. Ginkgo biloba leaf extract and kaempferol were found to have no effect ex-vivo on rat or mouse brain MAO or on concentrations of dopamine, noradrenaline, 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Kaempferol was shown to protect against NMDA-induced neuronal toxicity in-vitro in rat cortical cultures, but did not prevent DSP-4-induced noradrenergic neurotoxicity in an in-vivo model. Both Ginkgo biloba extract and kaempferol were demonstrated to be antioxidants in a lipid-peroxidation assay. This data indicates that the MAO-inhibiting activity of Ginkgo biloba extract is primarily due to the presence of kaempferol. Ginkgo biloba extract has properties indicative of potential neuroprotective ability.


Subject(s)
Flavonoids , Ginkgo biloba/chemistry , Kaempferols , Monoamine Oxidase Inhibitors/analysis , Neuroprotective Agents/pharmacology , Plant Extracts/pharmacology , Plant Leaves/chemistry , Plants, Medicinal , Quercetin/analogs & derivatives , 3,4-Dihydroxyphenylacetic Acid/metabolism , Administration, Oral , Animals , Brain/drug effects , Brain/enzymology , Brain/metabolism , Cells, Cultured , Chromatography, High Pressure Liquid , Dopamine/metabolism , Dose-Response Relationship, Drug , Hydroxyindoleacetic Acid/metabolism , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/enzymology , Male , Mice , Monoamine Oxidase/drug effects , Monoamine Oxidase/metabolism , Monoamine Oxidase Inhibitors/pharmacology , N-Methylaspartate/pharmacology , Neurons/cytology , Neurons/drug effects , Norepinephrine/metabolism , Plant Extracts/chemistry , Quercetin/analysis , Quercetin/pharmacology , Rats , Rats, Sprague-Dawley , Serotonin/metabolism , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/metabolism
10.
Acta Pharmacol Sin ; 21(12): 1145-52, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11603291

ABSTRACT

AIM: To determine the concentrations of chemical characteristic to extracts of leaves and flowers of Hypericum perforatum (St John's wort) in a number of selected samples and, following chemical characterization, to investigate the effects of these extracts on several pharmacological properties including effects of the extracts on inhibition of 5-hydroxytryptamine (5-HT) uptake and on antioxidant properties. METHODS: The samples were analyzed for the presence of characteristic chemicals by high performance liquid chromatography (HPLC) directly coupled to ultraviolet wavelength absorbance and positive or negative mode electrospray mass spectrometric detection. The effects of extracts on 5-HT uptake were determined by quantifying 3H-5-HT incorporation into rat hippocampal prisms. Estimates of effects of extracts on free radical scavenging capacity were made using a dynamic assay based on the ability of compounds to prevent the initiation of a colored reaction produced by the horseradish peroxidase catalyzed formation of hydroxyl free radicals from hydrogen peroxide using 2',2'-azinobis (3-ethylbenzthiazoline-6-sulfonic acid) as the color indicator. RESULTS: The chemical profile of a number of extracts were determined and found to differ substantially from each other. Inhibition of 5-HT uptake was found to correlate with hyperforin content and free radical scavenging capacity was found to correlate with the content of several flavonoids including quercetin and hyperoside. CONCLUSION: Standardized extracts of H perforatum varied substantially in the concentration of several characteristic chemicals. The correlation between pharmacological activity and certain characteristic chemicals found in these extracts indicates that the medicinal benefit derived from selected extracts will vary considerably depending on their chemical composition.


Subject(s)
Hypericum/chemistry , Perylene/analogs & derivatives , Quercetin/analogs & derivatives , Quercetin/pharmacology , Terpenes/pharmacology , Animals , Anthracenes , Antioxidants/pharmacology , Bridged Bicyclo Compounds , Free Radical Scavengers/pharmacology , Hippocampus/metabolism , Male , Perylene/isolation & purification , Perylene/pharmacology , Phloroglucinol/analogs & derivatives , Quercetin/isolation & purification , Rats , Rats, Sprague-Dawley , Selective Serotonin Reuptake Inhibitors/pharmacology , Terpenes/isolation & purification
11.
J Psychiatry Neurosci ; 24(5): 442-52, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10586535

ABSTRACT

OBJECTIVE: To determine if HT-1001, an extract of American ginseng, affects scopolamine-induced memory and performance deficits in a spatial learning task, alters brain concentrations of aminergic neurotransmitters, and alters choline uptake in synaptosome preparations. DESIGN: Animal study. ANIMALS: 48 Sprague Dawley rats. INTERVENTIONS: Long-term oral administration of a test material or control solution. Intraperitoneal administration of scopolamine (2 mg/kg) 30 minutes before testing. OUTCOME MEASURES: Performance on Morris water maze task, choline uptake, aminergic neurotransmitter analysis, in vitro monoamine oxidase analysis (of compounds). RESULTS: HT-1001 protected against scopolamine-induced amnesia and increased choline uptake in synaptosomal preparations. HT-1001 did not alter brain concentrations of norepinephrine, dopamine, 5-HT (serotonin), 3,4-dihydroxyphenylacetic acid or 5-hydroxyindoleactic acid. HT-1001 had a very weak ability to inhibit monoamine oxidase activity in vitro. CONCLUSIONS: HT-1001 demonstrates a capacity to protect against scopolamine-induced memory deficits.


Subject(s)
Central Nervous System Agents/pharmacology , Maze Learning/drug effects , Mental Recall/drug effects , Orientation/drug effects , Panax , Plants, Medicinal , Saponins/pharmacology , Scopolamine/toxicity , Animals , Ginsenosides , Male , Rats , Rats, Sprague-Dawley
12.
Gen Pharmacol ; 33(1): 73-81, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10428019

ABSTRACT

We have previously elucidated the opiate-like action of mitragynine, an active principle isolated from the Thai medicinal plant Mitragyna speciosa. In the present study, effects of the related compound, mitragynine pseudoindoxyl on electrically stimulated contraction in guinea pig ileum and mouse vas deferens, and on its binding affinity in the guinea pig brain membranes were studied. Mitragynine pseudoindoxyl inhibited the electrically stimulated ileum and mouse vas deferens contractions in a concentration-dependent manner. In the ileum, the effective concentration is in an nM order, being nearly equivalent to reported concentrations of the micro-opioid receptor agonist [D-Ala2, Met-Phe4, Gly-ol5] enkephalin (DAMGO), and is 100- and 20-fold smaller than those of mitragynine and morphine, respectively. In the vas deferens, it is 35-fold smaller than that of morphine. The inhibitory action of mitragynine pseudoindoxyl in the ileum was antagonized by the non-selective opioid receptor antagonist naloxone and the micro-receptor antagonist naloxonazine. It was also antagonized by the delta-receptor antagonist naltrindole in the vas deferens. Mitragynine pseudoindoxyl showed a similar binding affinity to DAMGO and naltrindole at micro- and delta-receptors, respectively. However, the affinity at kappa-receptors was negligible. The present study demonstrates that mitragynine pseudoindoxyl, a novel alkaloid structurally different from other opioid agonists, acts on opioid receptors, leading to a potent inhibition of electrically stimulated contraction in the ileum through the micro-receptors and in mouse vas deferens through delta-receptors.


Subject(s)
Analgesics/pharmacology , Plants, Medicinal/chemistry , Receptors, Opioid/agonists , Secologanin Tryptamine Alkaloids/pharmacology , Animals , Binding, Competitive , Brain/drug effects , Brain/metabolism , Dose-Response Relationship, Drug , Electric Stimulation , Guinea Pigs , Ileum/drug effects , Ileum/physiology , In Vitro Techniques , Male , Mice , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Muscle, Smooth/innervation , Muscle, Smooth/physiology , Naloxone/analogs & derivatives , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Receptors, Opioid/metabolism , Thailand , Vas Deferens/drug effects , Vas Deferens/physiology
13.
J Pharmacol Exp Ther ; 289(3): 1237-44, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10336511

ABSTRACT

Rutaecarpine (Rut) has been shown to induce hypotension and vasorelaxation. In vitro studies indicated that the vasorelaxant effect of Rut was largely endothelium-dependent. We previously reported that Rut increased intracellular Ca2+ concentrations ([Ca2+]i) in cultured rat endothelial cells (ECs) and decreased [Ca2+]i in cultured rat vascular smooth muscle (VSMCs) cells. The present results showed that the hypotensive effect of Rut (10-100 microgram/kg i.v.) was significantly blocked by the nitric oxide synthase inhibitor Nomega-nitro-L-arginine. In aortic rings, Rut (0. 1-3.0 microM)-induced vasorelaxation was inhibited by Nomega-nitro-L-arginine and hydroquinone but not by antagonists of the various K+ channels, 4-aminopyridine, apamin, charybdotoxin, or glibenclamide. Rut (0.1 and 1.0 microM) inhibited the norepinephrine-induced contraction generated by Ca2+ influx and at 1.0 microM increased cyclic GMP (cGMP) production in endothelium-intact rings and to a lesser extent in endothelium-denuded rings. In whole-cell patch-clamp recording, nonvoltage-dependent Ca2+ channels were recorded in ECs and Rut (0.1, 1.0 microM) elicited an opening of such channels. However, in VSMCs, Rut (10.0 microM) inhibited significantly the L-type voltage-dependent Ca2+ channels. In ECs cells, Rut (1.0, 10.0 microM) increased nitric oxide release in a Ca2+-dependent manner. Taken together, the results suggested that Rut lowered blood pressure by mainly activating the endothelial Ca2+-nitric oxide-cGMP pathway to reduce smooth muscle tone. Although the contribution seemed to be minor in nature, inhibition of contractile response in VSMCs, as evidenced by inhibition of Ca2+ currents, was also involved. Potassium channels, on the other hand, had no apparent roles.


Subject(s)
Alkaloids/pharmacology , Calcium Channels/physiology , Endothelium, Vascular/physiology , Isometric Contraction/drug effects , Muscle, Smooth, Vascular/physiology , Vasodilation/physiology , Vasodilator Agents/pharmacology , 4-Aminopyridine/pharmacology , Animals , Aorta, Thoracic/drug effects , Aorta, Thoracic/physiology , Calcium/metabolism , Calcium Channels, L-Type , Cells, Cultured , Cyclic GMP/metabolism , Endothelium, Vascular/drug effects , Hydroquinones/pharmacology , In Vitro Techniques , Indole Alkaloids , Male , Membrane Potentials/drug effects , Models, Cardiovascular , Muscle, Smooth, Vascular/drug effects , Nitroarginine/pharmacology , Norepinephrine/pharmacology , Patch-Clamp Techniques , Potassium Channel Blockers , Quinazolines , Rats , Rats, Sprague-Dawley , Vasodilation/drug effects
14.
Am J Hypertens ; 12(12 Pt 1-2): 1260-3, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10619591

ABSTRACT

Cells dissociated from spontaneously hypertensive rat (SHR) parathyroid glands were grown in culture. Media harvested from the cell cultures were analyzed for parathyroid hypertensive factor (PHF) using the blood pressure bioassay. Cells raised in DMEM containing normal (1.8 mmol/L) CaCl2 secreted a negligible amount of PHF, while cells cultured in Ham's F-12 medium containing low (0.3 mmol/L) CaCl2 secreted higher amounts of PHF. The PHF secretion in Ham's F-12 medium was highest in early passage cells, and was maintained for approximately 12 to 15 passages. PHF purified from the cell culture medium exhibited chromatographic properties identical to those previously described for PHF isolated from SHR plasma or SHR parathyroid gland organ culture medium. These results support the parathyroid gland as the organ of origin of PHF.


Subject(s)
Biological Factors/metabolism , Hypertension/metabolism , Parathyroid Glands/metabolism , Animals , Biomarkers , Blood Pressure , Calcium/blood , Cells, Cultured , Hypertension/physiopathology , Male , Parathyroid Glands/cytology , Parathyroid Glands/growth & development , Rats , Rats, Inbred SHR
15.
Regul Pept ; 77(1-3): 63-7, 1998 Oct 16.
Article in English | MEDLINE | ID: mdl-9809797

ABSTRACT

Pituitary adenylate cyclase activating polypeptide (PACAP) was shown to relax guinea pig gallbladder strips contracted with cholecystokinin. This relaxation was mediated by PACAP interacting with VIP/PACAP receptors. PACAP was also shown to cause contraction in guinea pig gallbladder strips. The present study demonstrated that calphostin C and bisindolylmaleimide IV, both blockers of protein kinase C, significantly reduced tension, Rp-adenosine 3', 5'-cyclic monophosphatase triethylamine, a blocker of protein kinase A, had no effect on PACAP-induced tension. Nifedipine also significantly reduced the PACAP effect. The contractile effects of PACAP are mediated by protein kinase C.


Subject(s)
Gallbladder/drug effects , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/drug effects , Neuropeptides/pharmacology , Protein Kinase C/metabolism , Animals , Calcitonin Gene-Related Peptide/pharmacology , Cholecystokinin/pharmacology , Cyclic AMP/analogs & derivatives , Cyclic AMP/pharmacology , Guinea Pigs , Indoles/pharmacology , Male , Maleimides/pharmacology , Naphthalenes/pharmacology , Nifedipine/pharmacology , Pituitary Adenylate Cyclase-Activating Polypeptide , Protein Kinase C/antagonists & inhibitors , Receptors, Vasoactive Intestinal Peptide/metabolism
16.
J Pharmacol Exp Ther ; 285(1): 16-21, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9535989

ABSTRACT

The present study was designed to investigate whether nitric oxide (NO) could interfere with intracellular Ca++ release through different pathways in vascular smooth muscle. Phasic contractions of rat aorta induced by phenylephrine or caffeine in Ca++-free solution were used as an indicator of intracellular Ca++ release through the inositol 1,4,5-triphosphate receptor pathway and the ryanodine receptor pathway, respectively. In addition, cytoplasmic Ca++ concentration ([Ca++]i) in vascular smooth muscle cells was determined by fluorescence measurement. Acetylcholine (ACh) inhibited the phenylephrine-evoked phasic contractions in Ca++-free solution in endothelium-intact but not -denuded aortic rings in a dose-dependent manner. However, ACh did not affect the action of caffeine. The inhibition by ACh was blocked completely by the NO synthase inhibitor Nomega-nitro-L-arginine, which could be reversed totally by L-arginine but not D-arginine. Methylene blue, a soluble guanylate cyclase inhibitor, also abolished the inhibition by ACh. Sodium nitroprusside, an NO donor, attenuated the phenylephrine- but not caffeine-induced phasic contractions in denuded aortic rings in Ca++-free solution. The effect of sodium nitroprusside was reversed substantially by methylene blue. Furthermore, sodium nitroprusside inhibited the elevation of [Ca++]i induced by phenylephrine in vascular smooth muscle cells isolated from rat aorta in the absence of extracellular Ca++, which could be abolished significantly by methylene blue. These results suggest that NO selectively inhibits intracellular Ca++ release stimulated by inositol 1,4,5-triphosphate, but not caffeine in vascular smooth muscle.


Subject(s)
Calcium/metabolism , Inositol 1,4,5-Trisphosphate/pharmacology , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/drug effects , Nitric Oxide/metabolism , Animals , Aorta/drug effects , Caffeine/pharmacology , Cardiotonic Agents/pharmacology , Male , Muscle, Smooth, Vascular/metabolism , Phenylephrine/pharmacology , Phosphodiesterase Inhibitors/pharmacology , Rats , Rats, Sprague-Dawley
17.
Regul Pept ; 72(1): 55-9, 1997 Sep 26.
Article in English | MEDLINE | ID: mdl-9404732

ABSTRACT

Calcitonin gene-related peptide (CGRP) has been shown to relax cholecystokinin-induced tension in guinea pig gallbladder strips. This relaxation is dependent on the concentration of CGRP, and is primarily due to the opening of ATP sensitive K+ channels; however, other mechanisms may also be involved. Studies using forskolin, 8-bromoadenosine 3', 5' cyclic monophosphate, dibutyryl cAMP, cholera toxin, and Rp-adenosine 3', 5'-cyclic monophosphothioate triethylamine, which measured changes in tension suggest that cAMP may be involved in mediating the actions of CGRP. Radioimmunoassay of strips precontracted with cholecystokinin octapeptide (CCK) and either treated with CGRP or its solvent demonstrated that cAMP concentrations increased with CGRP treatment. The results of these studies demonstrate that CGRP acts through multiple mechanisms to induce relaxation of guinea pig gallbladder strips precontracted with CCK.


Subject(s)
Calcitonin Gene-Related Peptide/pharmacology , Cyclic AMP/metabolism , Muscle Relaxation/drug effects , Muscle, Smooth/physiology , 8-Bromo Cyclic Adenosine Monophosphate/pharmacology , Adenylyl Cyclase Inhibitors , Animals , Bucladesine/pharmacology , Calcitonin Gene-Related Peptide/metabolism , Cholecystokinin/antagonists & inhibitors , Cholecystokinin/pharmacology , Cholera Toxin/pharmacology , Colforsin/pharmacology , Cyclic AMP/analogs & derivatives , Cyclic AMP/pharmacology , Enzyme Inhibitors/pharmacology , Enzyme-Linked Immunosorbent Assay , Gallbladder , Guinea Pigs , In Vitro Techniques , Male , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Rats , Thionucleotides/pharmacology
18.
J Exp Biol ; 200(Pt 20): 2669-74, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9359374

ABSTRACT

Cholecystokinin octapeptide (CCK), acetylcholine (ACh) and ceruletide have been shown to produce contraction in bullfrog (Rana catesbeiana) gallbladder strips. Agents capable of relaxing the bullfrog gallbladder are less numerous. Calcitonin gene-related peptide reduced the amount of both CCK- and ACh-induced tension in bullfrog gallbladder strips. The purpose of this study was to determine whether vasoactive intestinal peptide (VIP), nitric oxide (NO) and the second messengers cyclic GMP or cyclic AMP had any effect on gallbladder motility in the bullfrog. In vitro tension studies using l-NG-nitro-arginine methyl ester, Methylene Blue, sodium nitroprusside and N2,2'-O-dibutyryl guanosine 3',5'-cyclic monophosphate suggested that nitric oxide did not modulate gallbladder motility in the bullfrog gallbladder. Histochemical staining for NADPH diaphorase (nitric oxide synthase) failed to demonstrate nerve fibers containing nitric oxide synthase in the bullfrog gallbladder. In vitro studies demonstrated that VIP had no effect on CCK-induced tension. However, in vitro studies using either 8-bromoadenosine 3',5'-cyclic monophosphate or forskolin demonstrated that both agents relaxed strips precontracted with CCK. The results of this study suggested that, while neither NO nor VIP had a role in modulating bullfrog gallbladder motility, cyclic AMP was capable of modulating bullfrog gallbladder motility.


Subject(s)
Cyclic AMP/pharmacology , Gallbladder/physiology , Muscle Contraction/drug effects , Muscle, Smooth/physiology , Nitric Oxide/pharmacology , Rana catesbeiana , Animals
19.
Steroids ; 61(11): 657-63, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8916361

ABSTRACT

Pharmacological doses of 24R,25-dihydroxyvitamin D3 (24,25D3) inhibited both phasic and tonic contraction of Sprague-Dawley (SD) rat tail artery helical strips induced by KCl, norepinephrine (NE), and arginine vasopressin (AVP) in organ-bath studies. 24,25D3 also decreased the tension dependent on external calcium influx induced by KCl, AVP, and NE and the tension dependent on internal calcium release from intracellular calcium stores induced by NE. In vascular smooth muscle cells isolated from SD rat tail artery, 24,25D3 reduced membrane L-type calcium channel current and the increment of intracellular calcium concentration induced by KCl. It is suggested that 24,25D3 directly relaxed precontracted SD rat-tail artery by its inhibitory effect on plasma membrane and intracellular organelle calcium channels.


Subject(s)
24,25-Dihydroxyvitamin D 3/pharmacology , Calcium Channel Blockers/pharmacology , Calcium Channels/drug effects , Muscle, Smooth, Vascular/drug effects , Animals , Calcium/metabolism , Calcium Channels/metabolism , Cell Membrane/drug effects , Cell Membrane/metabolism , Male , Muscle, Smooth, Vascular/metabolism , Norepinephrine/pharmacology , Rats , Rats, Sprague-Dawley
20.
Planta Med ; 62(5): 431-5, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8923809

ABSTRACT

Tetramethylpyrazine (TMP) is a compound purified from a medicinal plant Ligusticum wallichii Franch. Its effects on in vivo blood pressure, in vitro vascular contractility, and intracellular calcium regulation in rats were examined in the present study to see if it was a possible calcium antagonist in the vascular tissue. Data showed that TMP was hypotensive and had a direct vascular effect. It not only blocked the entry of extracellular calcium through calcium channels but also inhibited the release of intracellular stored calcium in the vascular smooth muscle cell. It was a true calcium antagonist.


Subject(s)
Blood Pressure/drug effects , Calcium Channel Blockers/pharmacology , Calcium/metabolism , Muscle, Smooth, Vascular/physiology , Plants, Medicinal , Pyrazines/pharmacology , Animals , Arteries/drug effects , Arteries/physiology , In Vitro Techniques , Male , Membrane Potentials/drug effects , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/drug effects , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...